Page last updated: 2024-08-23

valrubicin and Neoplasms

valrubicin has been researched along with Neoplasms in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19903 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Blum, RH; Frei, E; Garnick, MB; Henderson, IC; Israel, M; Panellos, GP1
Blum, RH; Canellos, GP; Frei, E; Garnick, MB; Henderson, IC; Israel, M1
Bodley, AL; Hsiang, YH; Israel, M; Kirschenbaum, S; Liu, LF; Potmesil, M; Seshadri, R; Silber, R; Sweatman, TW1

Other Studies

3 other study(ies) available for valrubicin and Neoplasms

ArticleYear
Preclinical rationale and phase I clinical trial of the adriamycin analog, AD 32.
    Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer, 1981, Volume: 76

    Topics: Adolescent; Adult; Aged; Animals; Antineoplastic Agents; Doxorubicin; Drug Evaluation; Drug Evaluation, Preclinical; Humans; Middle Aged; Neoplasms; Neoplasms, Experimental; Rabbits

1981
Initial clinical evaluation of N-trifluoroacetyladriamycin-14-valerate (AD-32), an adriamycin analog.
    Cancer treatment reports, 1979, Volume: 63, Issue:5

    Topics: Doxorubicin; Drug Evaluation; Female; Humans; Male; Neoplasms

1979
Metabolic activation of N-acylanthracyclines precedes their interaction with DNA topoisomerase II.
    NCI monographs : a publication of the National Cancer Institute, 1987, Issue:4

    Topics: Animals; Biotransformation; Cell Line; DNA Topoisomerases, Type II; Doxorubicin; Drug Evaluation; Drug Evaluation, Preclinical; Humans; Mice; Mice, Inbred Strains; Neoplasms; Rats; Rats, Inbred Strains

1987